Economic News
-
Vipshop to Announce Fourth Quarter and Full Year 2024 Financial Results on February 21, 2025Details
GUANGZHOU,China,Feb. 11,2025--Vipshop Holdings Limited (NYSE: VIPS),a leading online discount retailer for brands in China ("Vipshop" or the "Company"),today announced that it plan
-
Clarendelle & Domaine Clarence Dillon Return as Official Wine Partner of the Academy of Motion Picture Arts and Sciences, Academy Museum of Motion Pictures and Exclusive Wines Poured at the 97th Oscars® Ceremony for the Third Year in a RowDetails
Clarendelle & Domaine Clarence Dillon will bring renowned Bordeaux wines to the film industry\'s biggest night
-
Open for Registration: The 3rd China-ASEAN Innovation and Entrepreneurship Competition (CAIEC-3) 2025Details
KUALA LUMPUR,Malaysia,Feb. 10,2025-- 2025 China – ASEAN Innovation and Entrepreneurship Competition is now calling for applications.
-
Alexandra Hospital develops world's novel A.I. algorithm (with international patent) that enhances accuracy and efficiency of robotic total knee replacementDetails
Newspoints: An A.I. algorithm for robotic total knee replacement (rTKR) has secured an international Patent Cooperation Treaty (PCT) patent[1],that protects this algorithm for robotic total knee repl
-
Rees Ward Transitions into Key Leadership Role at Bridgewest Group as Operating Partner and General Manager, New ZealandDetails
MIAMI and AUCKLAND,New Zealand,Feb. 12,2025-- Global private investment firm,Bridgewest Group,recognized for developing innovative companies in life sciences,software,and deep tech,is pleased to anno
-
From O Levels to a Medicine, Dentistry or Law Degree in Just 9 MonthsDetails
SINGAPORE,Feb. 11,2025-- With the growing demand for doctors,Singapore has increased the number of recognised foreign medical schools and ambitious students aiming for careers in medicine,dentistry or
-
NEOM Investment Fund partners with Paradromics to drive innovation in neurotechnology healthcareDetails
Strategic partnership with Paradromics will accelerate advancements in brain-computer interfaces and establish a Center of Excellence in NEOM.
-
Akeso Announced Enrollment of First Patient in Phase 3 Trial of Cadonilimab for Consolidation Therapy After Concurrent or Sequential Chemoradiotherapy in NSCLCDetails
HONG KONG,Feb. 13,2025--Akeso,Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized,double-blind,mult
-
WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive YearDetails
Ranked among the top 1% of companies assessed in the pharmaceutical industry Recognized as a leader in Green CRDMO,driving innovation for a healthier future
-
Caliway Announces CBL-514 Second Phase 2b Study Results (CBL-0205) Met EndpointsDetails
CBL-514,the world\'s first investigational drug for large-area localized fat reduction,has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3.